140 related articles for article (PubMed ID: 23197229)
21. Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study.
Bergenstal RM; Bode BW; Tamler R; Trence DL; Stenger P; Schachner HC; Fullam J; Pardo S; Kohut T; Fisher WA
Diabetes Technol Ther; 2012 Oct; 14(10):851-7. PubMed ID: 23013200
[TBL] [Abstract][Full Text] [Related]
22. Continuous Glucose Monitoring in Patients With Type 2 Diabetes.
Ann Intern Med; 2017 Sep; 167(6):. PubMed ID: 28828488
[No Abstract] [Full Text] [Related]
23. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.
Simon J; Gray A; Clarke P; Wade A; Neil A; Farmer A;
BMJ; 2008 May; 336(7654):1177-80. PubMed ID: 18420663
[TBL] [Abstract][Full Text] [Related]
24. Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).
Schneider B; Martin S; Heinemann L; Lodwig V; Kolb H
Arzneimittelforschung; 2007; 57(12):762-9. PubMed ID: 18380408
[TBL] [Abstract][Full Text] [Related]
25. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
26. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
[TBL] [Abstract][Full Text] [Related]
27. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
28. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycaemic control: a prospective study in insulin-treated diabetic patients.
Nyomba BL; Berard L; Murphy LJ
Diabet Med; 2004 Feb; 21(2):129-35. PubMed ID: 14984447
[TBL] [Abstract][Full Text] [Related]
29. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin.
Kempf K; Tankova T; Martin S
Diabetes Technol Ther; 2013 Jan; 15(1):89-96. PubMed ID: 23194054
[TBL] [Abstract][Full Text] [Related]
30. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
31. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
[TBL] [Abstract][Full Text] [Related]
32. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
Kanazawa Y; Igarashi Y; Komiya K; Sakurai Y; Shimizu T; Fujitani Y; Tanaka Y; Watada H; Kawamori R; Hirose T
Endocr J; 2007 Dec; 54(6):975-83. PubMed ID: 18000343
[TBL] [Abstract][Full Text] [Related]
34. Using continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetes.
McNally PG; Dean JD; Morris AD; Wilkinson PD; Compion G; Heller SR
Diabetes Care; 2007 May; 30(5):1044-8. PubMed ID: 17277042
[TBL] [Abstract][Full Text] [Related]
35. Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin.
Tildesley HD; Mazanderani AB; Ross SA
Diabetes Care; 2010 Aug; 33(8):1738-40. PubMed ID: 20668152
[TBL] [Abstract][Full Text] [Related]
36. Self-monitoring of blood glucose by adults with diabetes in the United States population.
Harris MI; Cowie CC; Howie LJ
Diabetes Care; 1993 Aug; 16(8):1116-23. PubMed ID: 8375241
[TBL] [Abstract][Full Text] [Related]
37. Overcoming Clinical Inertia: A Randomized Clinical Trial of a Telehealth Remote Monitoring Intervention Using Paired Glucose Testing in Adults With Type 2 Diabetes.
Greenwood DA; Blozis SA; Young HM; Nesbitt TS; Quinn CC
J Med Internet Res; 2015 Jul; 17(7):e178. PubMed ID: 26199142
[TBL] [Abstract][Full Text] [Related]
38. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
[TBL] [Abstract][Full Text] [Related]
39. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies.
Franciosi M; Pellegrini F; De Berardis G; Belfiglio M; Cavaliere D; Di Nardo B; Greenfield S; Kaplan SH; Sacco M; Tognoni G; Valentini M; Nicolucci A;
Diabetes Care; 2001 Nov; 24(11):1870-7. PubMed ID: 11679449
[TBL] [Abstract][Full Text] [Related]
40. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.
Polonsky WH; Fisher L; Schikman CH; Hinnen DA; Parkin CG; Jelsovsky Z; Axel-Schweitzer M; Petersen B; Wagner RS
Diabetes Technol Ther; 2011 Aug; 13(8):797-802. PubMed ID: 21568751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
